Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Practice Ownership

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Print Subscription

eNewsletter

The leading source of breaking news, news analysis, and emerging research reports in optometry, Optometry Times® disseminates practical content by optometrists for optometrists that can be immediately applied to improve the clinical experience.

Advertise

About Us

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times | Clinical News & Expert Optometrist Insights

Twitter

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

1rem

The Only Branded Steroid Indicated for Inflammation Associated With a Range of Ocular Surface Conditions

TobraDex ST: A Reliable Treatment for Blepharitis and Inflammation With Increased Ocular Bio-Availability

This program is sponsored by Eyevance Pharmaceuticals, a Santen company


An Effective and Comfortable Treatment Option for Ocular Itch Associated With Allergic Conjunctivitis